{"nct_id":"NCT02794519","title":"A Phase 2a Study to Evaluate the Effects of Sirukumab in Subjects With Severe Poorly Controlled Asthma","status":"WITHDRAWN","status_verified_date":"2018-08","start_date":"2016-09-23","start_date_type":"ACTUAL","primary_completion_date":"2016-10-04","primary_completion_date_type":"ACTUAL","completion_date":"2016-10-04","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["GSK"]}